Hepatic Encephalopathy
What's New
Last Posted: Dec 15, 2023
- MicroRNA-599-Regulated Susceptibility to Acute Kidney Injury in Patients with Cirrhosis is Mediated by the Sirtuin 1 (SIRT1) rs4746720 Single Nucleotide Polymorphism.
Fangfang Zhou, et al. Frontiers in bioscience (Landmark edition) 2023 0 (11) 318 - Clinical Profiles of Children With Sickle Cell Anaemia Presenting With Acute Clinical Events: A Single-Center Study.
Anwesha Singh et al. Cureus 2023 15(5) e39008 - Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with non-alcoholic fatty liver disease.
Chiara Rosso, et al. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023 0 - Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.
Wijarnpreecha Karn, et al. Digestive diseases and sciences 2017 0 (12) 3614-3621 - Toll-like receptor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascites.
Alvarado-Tapias Edilmar, et al. World journal of hepatology 2018 0 (1) 124-133 - Common NOD2 Risk Variants as Major Susceptibility Factors for Bacterial Infections in Compensated Cirrhosis.
Reichert Matthias Christian, et al. Clinical and translational gastroenterology 2019 0 (1) e00002 - The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency.
Shao Xue, et al. Digestive diseases (Basel, Switzerland) 2021 0 (5) 625-634 - Alpha-1-Antitrypsin Pi*MZ variant increases risk of developing hepatic events in nonalcoholic fatty liver disease patients.
Murali Arvind R, et al. Clinics and research in hepatology and gastroenterology 2022 0 (2) 102066 - Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients.
Gil-Gómez Antonio, et al. International journal of molecular sciences 2022 0 (19) - The Role of Vti1a in Biological Functions and Its Possible Role in Nervous System Disorders.
Tang Fajuan, et al. Frontiers in molecular neuroscience 2022 0 918664 - Sofosbuvir plus daclatasvir with or without ribavirin in 551 patients with hepatitis C-related cirrhosis, genotype 4.
El-Khayat H, et al. Alimentary pharmacology & therapeutics 2018 0 (5) 674-679 - Predicting graft failure in pediatric liver transplantation based on early biomarkers using machine learning models.
Jung Seungho et al. Scientific reports 2022 12(1) 22411 - Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi?MZ genotype.
Chen Vincent L, et al. JHEP reports : innovation in hepatology 2022 6 (6) 100483 - Artificial intelligence for hepatitis evaluation.
Liu Wei et al. World journal of gastroenterology 2021 27(34) 5715-5726 - Using machine learning methods to predict hepatic encephalopathy in cirrhotic patients with unbalanced data.
Yang Hong et al. Computer methods and programs in biomedicine 2021 211106420 - Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
Gil-Gómez Antonio, et al. The American journal of gastroenterology 2021 3 - Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications.
Kaliyaperumal Kalaiyarasi et al. Journal of hepatology 2018 Oct 69(4) 948-957 - Association between sarcopenia and hepatic encephalopathy: A systematic review and meta-analysis.
Wijarnpreecha Karn, et al. Annals of hepatology 2019 7 - Validation study associating glutaminase promoter variations with hepatic encephalopathy in East Asian populations.
Ahn Jem Ma, et al. Journal of gastroenterology and hepatology 2017 4 (4) 901-907 - PNPLA3 gene predicts clinical recovery after sustained virological response in decompensated hepatitis C cirrhosis.
Dunn Winston, et al. BMJ open gastroenterology 2019 0 (1) e000241
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 18, 2024
- Content source: